Mr Chris Nam
Higher Degree by Research Candidate
School of Medicine
College of Health
Eunwoo (Chris) Nam is a PhD candidate at the Centre for Cancer Biology, an alliance between Adelaide University and SA Pathology, in Adelaide, South Australia, Australia. For his PhD project, Chris works on investigating various ways to improve the efficacy of GD2 chimeric antigen receptor (CAR)-T cells against glioblastoma.
| Year | Citation |
|---|---|
| 2026 | Gardam, B., Gargett, T., Nam, E., Khan, S., Ormsby, R. J., Poonnoose, S. I., . . . Ebert, L. M. (2026). Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumor. Iscience, 29(3), 19 pages. Scopus1 WoS1 |
| 2026 | Gardam, B., Nam, E., Kollis, P. M., Kilyen-Coles, J., Lenin, S., Gliddon, B. L., . . . Gargett, T. (2026). A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumors. Clinical and Translational Immunology, 15(4), 19 pages. |
| 2024 | Lin, M. Y., Nam, E., Shih, R. M., Shafer, A., Bouren, A., Ceja, M. A., . . . Chen, Y. Y. (2024). Self-regulating CAR-T cells modulate cytokine release syndrome in adoptive T-cell therapy. Journal of Experimental Medicine, 221(6), 28 pages. Scopus29 WoS26 Europe PMC26 |
| 2020 | Zah, E., Nam, E., Bhuvan, V., Tran, U., Ji, B. Y., Gosliner, S. B., . . . Chen, Y. Y. (2020). Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma. Nature Communications, 11(1), 13 pages. Scopus187 WoS174 Europe PMC155 |
| 2017 | Li, S., Nih, L. R., Bachman, H., Fei, P., Li, Y., Nam, E., . . . Segura, T. (2017). Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability. Nature Materials, 16(9), 953-961. Scopus182 WoS169 Europe PMC137 |
Connect With Me
External Profiles
